Kosaku Murakami
Overview
Explore the profile of Kosaku Murakami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
124
Citations
1090
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Onishi A, Tanaka M, Fujii T, Murata K, Murakami K, Hashimoto M, et al.
Arthritis Res Ther
. 2025 Mar;
27(1):52.
PMID: 40055759
Background: While targeting the interleukin-6 receptor (IL-6R) through the use of sarilumab (SAR) or tocilizumab (TCZ) has become a major therapeutic approach for rheumatoid arthritis (RA), direct comparisons between IL-6R...
2.
Yoshida A, Murakami K, Tsukamoto H, Hotta Y, Nakayama Y, Saito R, et al.
Mod Rheumatol
. 2025 Mar;
PMID: 40048675
Objectives: Polyunsaturated fatty acids (PUFAs) are healthy fats that contain a double carbon bond. They are made up of omega (ω)-3 and ω-6 PUFAs, where ω-3 PUFAs exhibit beneficial effects,...
3.
Iwasaki T, Yoshifuji H, Kitagori K, Sumitomo S, Akizuki S, Nakashima R, et al.
Front Immunol
. 2025 Feb;
16:1506298.
PMID: 39975549
The factors contributing to the treatment efficacy of belimumab in patients with systemic lupus erythematosus (SLE) in the maintenance phase are unknown. Here, we collected blood samples from patients with...
4.
Ikezaki T, Murata K, Fujii T, Onishi A, Murakami K, Tanaka M, et al.
Int J Rheum Dis
. 2025 Feb;
28(2):e70131.
PMID: 39953762
Objectives: This longitudinal study investigated the factors associated with hallux valgus (HV) progression in patients with rheumatoid arthritis (RA). Methods: We included 316 patients with RA who underwent foot radiography...
5.
Ezzaldeen E, Yaguchi T, Imagawa R, Soltan M, Hirata A, Murakami K, et al.
Int Immunol
. 2025 Jan;
PMID: 39842944
Photodynamic therapy (PDT), a local cancer treatment using photosensitizers, has been reported to enhance antitumor immune responses by inducing immunogenic cell death. Although several studies have demonstrated the synergistic antitumor...
6.
Murata K, Uozumi R, Fujii T, Onishi A, Murakami K, Onizawa H, et al.
Sci Rep
. 2024 Dec;
14(1):30521.
PMID: 39690173
No abstract available.
7.
Nishimura N, Onishi A, Yamamoto W, Nagai K, Shiba H, Okita Y, et al.
Rheumatology (Oxford)
. 2024 Oct;
PMID: 39475445
Objectives: The impact of individual biological/targeted synthetic disease-modifying anti-rheumatic drug (b/tsDMARD) on kidney function in patients with rheumatoid arthritis (RA) remains unclear. This study aimed to determine the comparative effects...
8.
Saito R, Fujii T, Murata K, Onishi A, Murakami K, Tanaka M, et al.
Int J Rheum Dis
. 2024 Oct;
27(10):e15358.
PMID: 39373344
Objective: Osteoporosis and osteopenia are significant concerns in rheumatoid arthritis (RA), predisposing patients to fragility fractures. While dual-energy X-ray absorptiometry (DXA) is the gold standard for bone mineral density (BMD)...
9.
Doi H, Ohmura K, Hashimoto M, Ueno K, Takase Y, Inaba R, et al.
Lupus
. 2024 Sep;
33(12):1336-1344.
PMID: 39276161
Objectives: There are often discrepancies in the evaluation of disease activity between patients and physicians in systemic lupus erythematosus (SLE). In this study, we examined the factors that affect those...
10.
Yokoi M, Yonezawa A, Hira D, Handa T, Tanizawa K, Nakagawa S, et al.
J Pharm Health Care Sci
. 2024 Aug;
10(1):52.
PMID: 39192314
Background: Interstitial lung disease (ILD) is one of the most common fatal immune-related adverse events (irAEs). ILD development adversely affects the continuation of anticancer drug therapy, including immune checkpoint inhibitor...